Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Other Operating Expenses (2022 - 2025)

HCW Biologics (HCWB) has disclosed Other Operating Expenses for 6 consecutive years, with $13290.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses rose 17.51% year-over-year to $13290.0, compared with a TTM value of $89005.0 through Sep 2025, down 35.8%, and an annual FY2024 reading of $86990.0, down 91.35% over the prior year.
  • Other Operating Expenses was $13290.0 for Q3 2025 at HCW Biologics, down from $16373.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $383322.0 in Q1 2023 and bottomed at -$176397.0 in Q1 2022.
  • Average Other Operating Expenses over 5 years is $85415.4, with a median of $24749.0 recorded in 2025.
  • The sharpest move saw Other Operating Expenses crashed 100.0% in 2021, then surged 34297200.0% in 2022.
  • Year by year, Other Operating Expenses stood at -$1.0 in 2021, then soared by 34297200.0% to $342971.0 in 2022, then plummeted by 74.86% to $86235.0 in 2023, then plummeted by 59.89% to $34593.0 in 2024, then crashed by 61.58% to $13290.0 in 2025.
  • Business Quant data shows Other Operating Expenses for HCWB at $13290.0 in Q3 2025, $16373.0 in Q2 2025, and $24749.0 in Q1 2025.